Recently, it has been demonstrated that PI3K/AKT-dependent HO-1 induction drives drug resistance to imatinib in CML [190] as well as to panobinostat in AML [191] by modulating the expression of HDACs. The gene discussed is HMOX1; the disease is acute myeloid leukemia.